Bradmer Pharmaceuticals - Innovation in Cancer Therapy



	Bradmer Announces 2008 First Quarter Operational and Financial Results Investor Update - April 16, 2008 Bradmer Announces New Additions To Management Team Bradmer Appoints Robert Tessarolo To Board Of Directors 2007 Year End Results Webcast 10:00AM ET, March 12, 2008 Click here to listen to the replay>>> Bradmer Announces 2007 Fourth Quarter And Fiscal Year Operational And Financial Results Notice of Bradmer Pharmaceuticals Conference Call Bradmer Announces Phase II Results Published In Newly Diagnosed Glioblastoma Which Demonstrate Improved Survival And Support Upcoming Phase III Study Bradmer Announces Additions To Scientific Advisory Board Bradmer Provides Phase III Neuradiab Trial Update and Guidance Bradmer Announces Dr. Phil Gold To Join Board of Directors Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings Learn More



	Toronto Stock Exchange: BMR Per share amounts in Canadian Dollars Learn More